Extensively hydrolysed infant formulas: Need for aligned definition of peptide size characteristics and standardisation of analytical methods

S Nutten; M Kuslys; F Maynard; M Affolter; R G Heine; M E Levin; D M Blackhurst; F Kirstein; D Kok; G F Van der Watt; A D Marais

doi:10.7196/SAMJ.2018.v108i11.13616

Extensively hydrolysed infant formulas: Need for aligned definition of peptide size characteristics and standardisation of analytical methods

S Afr Med J. 2018 Oct 26;108(11):887-888. doi: 10.7196/SAMJ.2018.v108i11.13616.

Authors

S Nutten¹, M Kuslys, F Maynard, M Affolter, R G Heine, M E Levin, D M Blackhurst, F Kirstein, D Kok, G F Van der Watt, A D Marais

Affiliation

¹ Nestlé Health Science, Vevey, Switzerland. sophie.nutten@rdls.nestle.com.

PMID: 30645952
DOI: 10.7196/SAMJ.2018.v108i11.13616

Abstract

Letter by Nutten et al. on article by Levin et al. (Levin ME, Blackhurst DM, Kirstein F, Kok D, van der Watt GF, Marais AD. Residual allergenicity of amino acid-based and extensively hydrolysed cow's milk formulas. S Afr Med J 2017;107(9):763-767. S Afr Med J 2017;107(3):258-263. https://doi.org/10.7196/SAMJ.2017.v107i9.12137); and response by Levin et al.

Publication types

Letter
Comment